LoadingSUPV
Pizzulli Diego Alejandro reported Grant or award in Grupo Supervielle S.A.: 1980789 units of Stock Options (Right to Buy) (derivative), dated 2026-10-05. The full Form 4 contains 1 transaction entry.
VFS
Vuong Pham Nhat reported Sale in VinFast Auto Ltd.: 479745716 units of FVN Series 1A Pref Shares - Call Option (obligated to sell) (derivative), dated 2026-10-05. The full Form 4 contains 6 transaction entries.
ARTV
Aslan Fred reported Sale in Artiva Biotherapeutics, Inc.: 61696 units of Common Stock, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
ARTV
Banerjee Subhashis reported Sale in Artiva Biotherapeutics, Inc.: 1099 units of Common Stock, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
ARTV
Bush Jennifer reported Sale in Artiva Biotherapeutics, Inc.: 8370 units of Common Stock, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
NXH
LEMONIS MARCUS reported Purchase in NEIGHBORHOOD INTELLIGENCE, INC.: 362319 units of Common Stock, dated 2026-10-06. The full Form 4 contains 1 transaction entry.
ELV
Kaye Mark reported Tax/exercise withholding in Elevance Health, Inc.: 4161 units of Common Stock, dated 2026-10-02. The full Form 4 contains 2 transaction entries.
ARTV
Horan Christopher reported Sale in Artiva Biotherapeutics, Inc.: 10340 units of Common Stock, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
SLP
OCONNOR SHAWN reported Disposition to issuer in Simulations Plus, Inc.: 50000 units of Stock Options (Right to Buy) (derivative), dated 2026-10-06. The full Form 4 contains 7 transaction entries.
ACN
Walsh John F reported Grant or award in Accenture plc: 139 units of Class A ordinary shares, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
ACN
Sharma Manish reported Grant or award in Accenture plc: 93 units of Class A ordinary shares, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
SLP
WOLTOSZ WALTER S; WOLTOSZ VIRGINIA E reported Disposition to issuer in Simulations Plus, Inc.: 3202131 units of Common Stock, dated 2026-10-06. The full Form 4 contains 2 transaction entries.
ACN
Clifford Katherine Lee reported Grant or award in Accenture plc: 89 units of Class A ordinary shares, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
ACN
Unruch Joel reported Grant or award in Accenture plc: 140 units of Class A ordinary shares, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
ACN
Sweet Julie Spellman reported Grant or award in Accenture plc: 197 units of Class A ordinary shares, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
ACN
Park Angie Y reported Grant or award in Accenture plc: 140 units of Class A ordinary shares, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
ACN
Burgum Melissa A reported Grant or award in Accenture plc: 101 units of Class A ordinary shares, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
EVLV
Glat Neil reported Disposition to issuer in Evolv Technologies Holdings, Inc.: 17500 units of Class A Common Stock, dated 2026-07-16. The full Form 4 contains 2 transaction entries.
HNGE
Sloat Tyler reported 175 shares of Class A Common Stock in Hinge Health, Inc. as grants or awards dated 2026-10-05. The Form 4 was disclosed on Oct 6, 2026. These were stock awards, not open-market purchases.
SLP
WEINER DANIEL L reported Disposition to issuer in Simulations Plus, Inc.: 16547 units of Common Stock, dated 2026-10-06. The full Form 4 contains 3 transaction entries.
GLUE
Bowen Matthew reported Sale in Monte Rosa Therapeutics, Inc.: 13 units of Common Stock, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
NTLA
Dube Michael P reported Sale in Intellia Therapeutics, Inc.: 1864 units of Common Stock, dated 2026-10-02. The full Form 4 contains 1 transaction entry.
SLP
Paglia John Kenneth reported Disposition to issuer in Simulations Plus, Inc.: 14589 units of Common Stock, dated 2026-10-06. The full Form 4 contains 3 transaction entries.
SLP
FREDERICK WILLIAM W reported Disposition to issuer in Simulations Plus, Inc.: 2100 units of Common Stock, dated 2026-10-06. The full Form 4 contains 6 transaction entries.
